INSIDERFilingvia Quantisnow
Quotient Limited logo

Quotient (QTNT) director von Prondzynski bought 100,000 shares for $18.1K at $0.18

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Heino von Prondzynski (director at Quotient Limited, QTNT) reported that they bought 100,000 shares for $18.1K at $0.18 on Sep 1, 2022. After these transactions the filing shows 505,879 shares held directly.

Reporting person
von Prondzynski Heino
Common stock and other non-derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Sep 1, 2022Open-market purchase (P)Ordinary Shares+100,000$0.18$18.1K505,879 direct

Holdings before and after

  • Ordinary Shares: 405,879 to 505,879 direct

Footnotes from the filing

  1. 1. Restricted Stock Units convert into ordinary shares on a one-for-one basis.
  2. 2. All 4,303 options have vested and remain exercisable.
  3. 5. On October 31, 2021, the Reporting Person was granted 69,041 restricted stock units, of which 51,780 have vested and have converted into ordinary shares. The remaining 17,261 restricted stock units will vest on October 31, 2022.

Transaction codes in this filing

Open-market purchase:
Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

FAQ

What did von Prondzynski report in this QTNT Form 4?

Heino von Prondzynski (director at Quotient Limited, QTNT) reported that they bought 100,000 shares for $18.1K at $0.18 on Sep 1, 2022. After these transactions the filing shows 505,879 shares held directly.

How many QTNT shares does von Prondzynski hold after this filing?

The filing shows 505,879 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.

What does transaction code P mean on an SEC Form 4?

Code P marks a purchase in the open market or a private deal. The insider paid for these securities.

Historical context for QTNT

Earlier insider filings at QTNT

Quantisnow market dataNASDAQ
Quotient Limited logo
QTNT
Quotient Limited
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Listed since
2014
Get push alerts for QTNT

Follow QTNT and get a push notification the moment its next story breaks.

Full QTNT profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track QTNT (Quotient Limited) and more on Quantisnow.